scispace - formally typeset
J

Joseph J.Y. Sung

Researcher at The Chinese University of Hong Kong

Publications -  1287
Citations -  107508

Joseph J.Y. Sung is an academic researcher from The Chinese University of Hong Kong. The author has contributed to research in topics: Cancer & Colorectal cancer. The author has an hindex of 142, co-authored 1240 publications receiving 92035 citations. Previous affiliations of Joseph J.Y. Sung include University of London & Technion – Israel Institute of Technology.

Papers
More filters
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

Daniel J. Klionsky, +2522 more
- 21 Jan 2016 - 
TL;DR: In this paper, the authors present a set of guidelines for the selection and interpretation of methods for use by investigators who aim to examine macro-autophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes.
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy

Daniel J. Klionsky, +1287 more
- 01 Apr 2012 - 
TL;DR: These guidelines are presented for the selection and interpretation of methods for use by investigators who aim to examine macroautophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes.
Journal ArticleDOI

Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies

TL;DR: The changing incidence and prevalence of inflammatory bowel disease around the world has become a global disease with accelerating incidence in newly industrialised countries whose societies have become more westernised and burden remains high as prevalence surpasses 0·3%.
Journal ArticleDOI

A Major Outbreak of Severe Acute Respiratory Syndrome in Hong Kong

TL;DR: SARS is a serious respiratory illness that led to significant morbidity and mortality in this cohort of 138 cases of suspected SARS during a hospital outbreak in Hong Kong.
Journal ArticleDOI

Lamivudine for Patients with Chronic Hepatitis B and Advanced Liver Disease

TL;DR: Continuous treatment with lamivudine delays clinical progression in patients with chronic hepatitis B and advanced fibrosis or cirrhosis by significantly reducing the incidence of hepatic decompensation and the risk of hepatocellular carcinoma.